WuXi, Regeneron In Buying Range Despite Market's Woes
Medical stocks WuXi PharmaTech (WX) and Regeneron Pharmaceuticals (REGN) are in buying range after holding up relatively well amid the market's post-election sell-off. China-based WuXi -- an outsourcing company offering pharmaceutical, biotechnology and medical device research -- is just above a 15.10 buy point in a long base. The stock has an alternative buy point at 15.70, which WuXi topped Thursday but in light trade. WuXi broke out above the
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here